XERS — Xeris Biopharma Holdings Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Xeris Biopharma Holdings Inc (XERS), worth $6.49M combined. Over the quarter 0 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Essex | $5.67M | 0.74% | -4.3% |
| Renaissance | $533.31K | 0.00% | -85.1% |
| Persistent | $282.44K | 0.09% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.